[vc_row top_margin=”none” el_position=”first”] [vc_column top_margin=”none”] [mc_carousel id=”carousel” carousel_images=”2773,2772,2771,2770″ features_images_loop=”1″ lightbox_icon_color=”blue_light” autoplay=”0″ pause_on_hover=”1″ scroll=”1″ effect=”scroll” easing=”swing” duration=”500″ top_margin=”page_margin_top_section” el_position=”first last”] [/vc_column] [/vc_row] [vc_row top_margin=”none” el_position=”last”] [vc_column top_margin=”none”] [vc_column_text el_position=”first last”]

Imfinzi Is First Immunotherapy Approved for Advanced Non-small Cell Lung Cancer in US
February 21, 2018
https://immuno-oncologynews.com/2018/02/21/imfinzi-first-fda-approved-treatment-non-small-cell-lung-cancer/

Lycera Starts Phase 1b Trial of Non-small Cell Lung Cancer Combo Therapy of immunotherapy LYC-55716 and Merck’s Keytruda (pembrolizumab) as a Lung Cancer Therapy.
January, 2018
https://immuno-oncologynews.com/2018/01/10/lycera-starts-phase-1b-trial-of-combo-therapy-for-non-small-cell-lung-cancer/

FDA Approves Nivolumab for Advanced Non-Squamous NSCLC
Cancer Network
October, 2015
http://www.cancernetwork.com/lung-cancer/fda-approves-nivolumab-advanced-non-squamous-nsclc

A Novel Antibody-Drug Conjugate for Lung Cancer: An interview with Dr. Camidge from University of Colorado about an early stage lung cancer trial of IMMU-132.
Cancer Network
September, 2015
http://www.cancernetwork.com/wclc-2015/novel-antibody-drug-conjugate-chemotherapy-future-lung-cancer

Afatinib plus cetuximab shows promise in EGRF-mutated lung cancer
HemOnc Today
July 31, 2014
http://www.healio.com/hematology-oncology/lung-cancer/news/online/%7B71099a79-b4ea-477b-8d6b-941b9fcba816%7D/afatinib-plus-cetuximab-shows-promise-for-egfr–mutated-lung-cancer

Astrazeneca spartners with Roche, Qiagen for co-development of lung cancer diagnostics
Tech Times
July 30, 2014
http://www.techtimes.com/articles/11508/20140730/astrazeneca-partners-with-roche-qiagen-for-co-development-of-lung-cancer-diagnostics.htm

Treatment Combo for EGFR Inhibitor-Resistant Lung Cancer
Cancer Network
July 29, 2104
http://www.cancernetwork.com/lung-cancer/treatment-combo-egfr-inhibitor-resistant-lung-cancer

Drug Candidate AZD3965 Slows Tumor Growth
HealthLine
July 16, 2014
http://www.healthline.com/health-news/emerging-treatments-for-small-cell-lung-cancer-071614

[/vc_column_text] [/vc_column] [/vc_row]